Public stock offering pulls in $22.6M for InspireMD

04/23/2013 | MassDevice.com (Boston)

InspireMD has secured net proceeds of $22.6 million in a public offering of company shares. The Israeli device firm will use part of the funding to seek FDA approval of its MGuard carotid and coronary stents, which are used to prevent the risk of embolism in patients who have undergone stenting procedures.

View Full Article in:

MassDevice.com (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Director of Operations - GBS
Mayo Clinic
Rochester, MN
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Senior Vice President, Clinical Affairs & Strategic Partnerships
America's Health Insurance Plans (AHIP)
Washington, DC